BioLife (BLFS) Reports Q1 2026 Earnings with Revenue Growth
BioLife reported total revenue of $27.5 million for Q1 2026, a 25% increase year-over-year. Adjusted EBITDA rose to $6.2 million (22% of revenue), up approximately 15%. The company highlighted strong performance in its Biopreservation media segment and expansion into commercial therapies.
Tickers: $BLFS
Topics: adjusted_ebitda biopreservation_media commercial_therapies revenue